RxDoctor Payments Data

James Block, MD

Family Medicine · Oklahoma City, OKNPI 1093277444

Payments from drug & device makers

$826in general payments, 2019–2025

Across 44 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$146
  • Pfizer$105
  • Lilly USA, LLC$86
  • Viiv Healthcare Company$82
  • AstraZeneca$64
  • Johnson & Johnson$61
  • plus $281 from 10 others

What the payments were for

  • Food & beverage$826100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$826 in reported general payments places this provider in the 60th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$40,167
Medicare patients
91
Services billed
389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide12$15,085
JardianceEmpagliflozin24$14,644
OzempicSemaglutide11$9,352
Atorvastatin Calcium179$2,107
Lisinopril84$1,054
Losartan Potassium104$1,054
Amlodipine Besylate100$961
Tamsulosin Hcl40$514
Allopurinol42$384
Levothyroxine Sodium40$378
Gabapentin33$370
Pantoprazole Sodium22$352
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide24$352
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide26$324
Metoprolol Succinate30$312

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$86$15,08512 claims
Boehringer IngelheimJardiance$15$14,64424 claims
Novo NordiskOzempic$51$9,35211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →